Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Oseshnyuk, Rodion A
6  Ergebnisse:
Personensuche X
?
1

Safety and Immunogenicity of Betuvax-CoV-2, an RBD-Fc-Based..:

Kudriavtsev, Aleksandr V. ; Vakhrusheva, Anna V. ; Kryuchkov, Nickolay A....
Vaccines.  11 (2023)  2 - p. 326 , 2023
Link: https://doi.org/10.3390/..
 
?
2

Experience of determination of antitumor drugs concentratio..:

Rodionov, Gennadii G ; Shantyr', Igor I ; Ushal, Inna E...
Reviews on Clinical Pharmacology and Drug Therapy.  16 (2018)  1 - p. 64-70 , 2018
Link: https://doi.org/10.17816..
 
?
3

Safety and Immunogenicity of Betuvax-CoV-2, an RBD-Fc-Based..:

Kudriavtsev, Aleksandr V ; Vakhrusheva, Anna V ; Kryuchkov, Nickolay A...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9965088/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
4

Phase 3 trial of coronavir (favipiravir) in patients with m..:

Ruzhentsova, Tatiana A ; Oseshnyuk, Rodion A ; Soluyanova, Tatyana N...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8661194/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
5

Safety and Immunogenicity of Betuvax-CoV-2, an RBD-Fc-Based..:

Aleksandr V. Kudriavtsev ; Anna V. Vakhrusheva ; Nickolay A. Kryuchkov...
COVID-19 Vaccines and Vaccination.  , 2023
Link: https://doi.org/10.3390/..
 
?
6

Safety and Immunogenicity of Betuvax-CoV-2, an RBD-Fc-Based..:

Aleksandr V. Kudriavtsev ; Anna V. Vakhrusheva ; Nickolay A. Kryuchkov...
https://www.mdpi.com/2076-393X/11/2/326.  , 2023
Link: https://doi.org/10.3390/..
 
1-6